Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02924766
Title A Safety and Pharmacokinetics Study of Niraparib Plus Apalutamide in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC

prostate cancer


Apalutamide + Niraparib

Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.